Select Publications
Journal articles
2021, '535The epidemiology of all-cause and cause-specific mortality following release from prison in 11 countries', International Journal of Epidemiology, 50, http://dx.doi.org/10.1093/ije/dyab168.091
,2021, 'Mapping drug epidemiology futures', International Journal of Drug Policy, 94, http://dx.doi.org/10.1016/j.drugpo.2021.103378
,2021, 'Association between Opioid Agonist Therapy and Testing, Treatment Uptake, and Treatment Outcomes for Hepatitis C Infection among People Who Inject Drugs: A Systematic Review and Meta-analysis', Clinical Infectious Diseases, 73, pp. E107 - E118, http://dx.doi.org/10.1093/cid/ciaa612
,2021, 'Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta-analysis', Addiction, 116, pp. 1664 - 1676, http://dx.doi.org/10.1111/add.15316
,2021, 'A rapid review of the impacts of “Big Events ” on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19', International Journal of Drug Policy, 92, http://dx.doi.org/10.1016/j.drugpo.2021.103127
,2021, 'All-cause and cause-specific mortality among people with regular or problematic cocaine use: a systematic review and meta-analysis', Addiction, 116, pp. 725 - 742, http://dx.doi.org/10.1111/add.15239
,2021, 'Modelling the intervention effect of opioid agonist treatment on multiple mortality outcomes in people who inject drugs: a three-setting analysis', The Lancet Psychiatry, 8, pp. 301 - 309, http://dx.doi.org/10.1016/S2215-0366(20)30538-1
,2021, 'What predicts pharmacists’ engagement with opioid-outcome screening? Secondary analysis from an implementation study in community pharmacy', International Journal of Clinical Pharmacy, 43, pp. 420 - 429, http://dx.doi.org/10.1007/s11096-020-01074-5
,2021, 'Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001–2018: Implications for treatment systems and potential impact on client outcomes', Drug and Alcohol Dependence, 219, http://dx.doi.org/10.1016/j.drugalcdep.2020.108464
,2021, 'The next wave? Mental health comorbidities and patients with substance use disorders in under-resourced and rural areas', Journal of Substance Abuse Treatment, 121, http://dx.doi.org/10.1016/j.jsat.2020.108189
,2021, 'Feasibility and acceptability of take-home naloxone for people released from prison in New South Wales, Australia', Drug and Alcohol Review, 40, pp. 98 - 108, http://dx.doi.org/10.1111/dar.13144
,2021, 'Hospitalisations for non-fatal overdose among people with a history of opioid dependence in New South Wales, Australia, 2001–2018: Findings from the OATS retrospective cohort study', Drug and Alcohol Dependence, 218, http://dx.doi.org/10.1016/j.drugalcdep.2020.108354
,2020, 'Using Linked Data to Examine the Epidemiology of All-Cause and Cause-Specific Mortality Following Release from Incarceration in Eleven Countries', International Journal of Population Data Science, 5, http://dx.doi.org/10.23889/ijpds.v5i5.1478
,2020, 'Data Resource Profile: The Opioid Agonist Treatment and Safety (OATS) Study, New South Wales, Australia', International Journal of Epidemiology, 49, pp. 1774 - 1775G, http://dx.doi.org/10.1093/ije/dyaa125
,2020, 'Global opioid agonist treatment: a review of clinical practices by country', Addiction, 115, pp. 2243 - 2254, http://dx.doi.org/10.1111/add.15087
,2020, 'Risk of discharge against medical advice among hospital inpatients with a history of opioid agonist therapy in New South Wales, Australia: A cohort study and nested crossover-cohort analysis', Drug and Alcohol Dependence, 217, http://dx.doi.org/10.1016/j.drugalcdep.2020.108343
,2020, 'Routine opioid outcome monitoring in community pharmacy: Outcomes from an open-label single-arm implementation-effectiveness pilot study', Research in Social and Administrative Pharmacy, 16, pp. 1694 - 1701, http://dx.doi.org/10.1016/j.sapharm.2020.02.009
,2020, 'Profile and correlates of injecting-related injuries and diseases among people who inject drugs in Australia', Drug and Alcohol Dependence, 216, pp. 108267, http://dx.doi.org/10.1016/j.drugalcdep.2020.108267
,2020, 'Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis', International Journal of Drug Policy, 84, http://dx.doi.org/10.1016/j.drugpo.2020.102866
,2020, 'Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia', Addiction, 115, pp. 1295 - 1305, http://dx.doi.org/10.1111/add.14941
,2020, 'Frequency of health-care utilization by adults who use illicit drugs: a systematic review and meta-analysis', Addiction, 115, pp. 1011 - 1023, http://dx.doi.org/10.1111/add.14892
,2020, 'All-Cause and Cause-Specific Mortality among People Using Extramedical Opioids: A Systematic Review and Meta-analysis', JAMA Psychiatry, 77, pp. 493 - 502, http://dx.doi.org/10.1001/jamapsychiatry.2019.4170
,2020, 'Socio-demographic and ecological factors associated with anti-HCV prevalence in people who inject drugs: A systematic review', Drug and Alcohol Dependence, 209, http://dx.doi.org/10.1016/j.drugalcdep.2020.107899
,2020, 'Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence', International Journal of Drug Policy, 77, http://dx.doi.org/10.1016/j.drugpo.2019.102656
,2020, 'Depression, post-traumatic stress disorder, suicidality and self-harm among people who inject drugs: A systematic review and meta-analysis', Drug and Alcohol Dependence, 207, http://dx.doi.org/10.1016/j.drugalcdep.2019.107793
,2020, 'Frequency of injecting among people who inject drugs: A systematic review and meta-analysis', International Journal of Drug Policy, 76, http://dx.doi.org/10.1016/j.drugpo.2019.102619
,2020, 'The Mortality after Release from Incarceration Consortium (MARIC): Protocol for a multi-national, individual participant data meta-analysis.', International Journal of Population Data Science, 5, pp. 1145, http://dx.doi.org/10.23889/ijpds.v5i1.1145
,2020, 'All-Cause and Overdose Mortality Risk among People Prescribed Opioids: A Systematic Review and Meta-analysis', Pain Medicine (United States), 21, pp. 3700 - 3711, http://dx.doi.org/10.1093/PM/PNAA214
,2020, 'Associations between national development indicators and the age profile of people who inject drugs: results from a global systematic review and meta-analysis', The Lancet Global Health, 8, pp. e76 - e91, http://dx.doi.org/10.1016/S2214-109X(19)30462-0
,2020, 'Prevalence of injecting drug use and coverage of interventions to prevent HIV and hepatitis C virus infection among people who inject drugs in Canada', American Journal of Public Health, 110, pp. 45 - 50, http://dx.doi.org/10.2105/AJPH.2019.305379
,2020, 'Use of alcohol swabs to clean injecting sites among people who regularly inject drugs in Australia', Drug and Alcohol Review, 39, pp. 83 - 92, http://dx.doi.org/10.1111/dar.13006
,2020, 'Frequency of injecting among people who inject drugs: A systematic review and meta-analysis.', Int J Drug Policy, 76, pp. 102619, http://dx.doi.org/10.1016/j.drugpo.2019.102619
,2019, 'Modelling the potential prevention benefits of a treat-all hepatitis C treatment strategy at global, regional and country levels: A modelling study', Journal of Viral Hepatitis, 26, pp. 1388 - 1403, http://dx.doi.org/10.1111/jvh.13187
,2019, 'The prevalence of non-fatal overdose among people who inject drugs: A multi-stage systematic review and meta-analysis', International Journal of Drug Policy, 73, pp. 172 - 184, http://dx.doi.org/10.1016/j.drugpo.2019.07.030
,2019, 'Global patterns of opioid use and dependence: harms to populations, interventions, and future action', The Lancet, 394, pp. 1560 - 1579, http://dx.doi.org/10.1016/S0140-6736(19)32229-9
,2019, 'Mortality among people with regular or problematic use of amphetamines: a systematic review and meta-analysis', Addiction, 114, pp. 1738 - 1750, http://dx.doi.org/10.1111/add.14706
,2019, 'Reductions in emergency department presentations associated with opioid agonist treatment vary by geographic location: A retrospective study in New South Wales, Australia', Drug and Alcohol Review, 38, pp. 690 - 698, http://dx.doi.org/10.1111/dar.12976
,2019, 'Prevalence of HIV, HCV and HBV infection and sociodemographic characteristics of people who inject drugs in China: A systematic review and meta-analysis', International Journal of Drug Policy, 70, pp. 87 - 93, http://dx.doi.org/10.1016/j.drugpo.2019.05.005
,2019, 'Protocol for the Data-Linkage Alcohol Cohort Study (DACS): Investigating mortality, morbidity and offending among people with an alcohol-related problem using linked administrative data', BMJ Open, 9, http://dx.doi.org/10.1136/bmjopen-2019-030605
,2019, 'The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study', The Lancet Public Health, 4, pp. e334 - e342, http://dx.doi.org/10.1016/S2468-2667(19)30060-X
,2019, 'A Global Meta-analysis of the Prevalence of HIV, Hepatitis C Virus, and Hepatitis B Virus among People Who Inject Drugs - Do Gender-Based Differences Vary by Country-Level Indicators?', Journal of Infectious Diseases, 220, pp. 78 - 90, http://dx.doi.org/10.1093/infdis/jiz058
,2019, 'The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study', The Lancet Gastroenterology and Hepatology, 4, pp. 435 - 444, http://dx.doi.org/10.1016/S2468-1253(19)30085-8
,2019, 'A population-based study of transdermal fentanyl initiation in Australian clinical practice', European Journal of Clinical Pharmacology, 75, pp. 401 - 408, http://dx.doi.org/10.1007/s00228-018-2588-0
,2019, 'Uptake of direct acting antiviral therapies for the treatment of hepatitis C virus among people who inject drugs in a universal health-care system', Drug and Alcohol Review, 38, pp. 264 - 269, http://dx.doi.org/10.1111/dar.12883
,2019, 'A major expansion of opioid agonist treatment is needed to reduce overdose deaths in the USA', The Lancet Public Health, 4, pp. e77 - e78, http://dx.doi.org/10.1016/S2468-2667(19)30001-5
,2019, 'Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugs', Addiction, 114, pp. 150 - 166, http://dx.doi.org/10.1111/add.14393
,2018, 'Combating escalating harms associated with pharmaceutical opioid use in Australia: The POPPY II study protocol', BMJ Open, 8, http://dx.doi.org/10.1136/bmjopen-2018-025840
,2018, 'Current Opioid Access, Use, and Problems in Australasian Jurisdictions', Current Addiction Reports, 5, pp. 464 - 472, http://dx.doi.org/10.1007/s40429-018-0227-6
,2018, 'Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol.', Res Social Adm Pharm, http://dx.doi.org/10.1016/j.sapharm.2018.10.024
,2018, 'Competing global statistics on prevalence of injecting drug use: why does it matter and what can be done?', Addiction, 113, pp. 1768 - 1774, http://dx.doi.org/10.1111/add.14383
,